Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. (MDGL) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mdgl · stock forecast · 23 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 23 Wall Street analysts in the past 3 months
Buy
23 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$964
Consensus
$731
+50.2% upside
Low
$571
Median: $679 · Last Close: $486.98
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$731.25
50.2% upside
High Target
$964
98.0%
Low Target
$571
17.3%
Current Price
$486.98
as of today
Based on analyst price targets, the MDGL stock price prediction for the next 12 months ranges from $571 to $964. The consensus MDGL price forecast of $731.25 implies 50.2% upside from the current price of $486.98.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $469.65 | ↓ 3.56% |
1-day model range: $467.05–$472.25. Peak: $472.25 (-3.56%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $609 | +25.1% |
| 2028 | $709 | +45.6% |
| 2029 | $784 | +61.0% |
| 2030 | $838 | +72.2% |
| 2031 | — | +79.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MDGL · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-07 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-20 | B of A Securities | Maintains | Neutral→Neutral |
| 2026-01-20 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-19 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-12-11 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-11-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-20 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Madrigal Pharmaceuticals, Inc. (MDGL) stock. Of the recent 115 rating actions, 8 were upgrades and 6 were downgrades. 23 analysts currently cover MDGL.
Analyst Recommendation Trends
MDGL analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 4 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.5B
↓ 50.2% YoY
Revenue Next Year
$2.2B
↑ 48.6% YoY
EPS This Year
$-6.55
EPS Next Year
$10.54
↓ 261.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MDGL EPS of $-6.55 for the current fiscal year, based on estimates from 8 analysts. The MDGL revenue forecast is $1.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MDGL stock forecast is supported by two independent data sources: analyst consensus ratings from 23 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MDGL price target is $731.25 (+50.2% upside), with an analyst consensus of Buy.
The MDGL short-term stock prediction for tomorrow is $469.65 (-3.56%). The MDGL stock price prediction for 2027 estimates an average of $609. The MDGL stock prediction for 2030 projects a range of $788–$889.
Madrigal Pharmaceuticals, Inc. trades on NASDAQ under the ticker MDGL. The MDGL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 87% of covering analysts.
Frequently asked questions
MDGL forecast · 8 questionsAccording to 23 Wall Street analysts, the average 12-month MDGL price target is $731.25, with a high forecast of $964.00 and a low of $571.00. The median price target is shown in the chart above when available. This implies +50.2% potential upside from the current price of $486.98.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.